NEXGEL, Inc (NXGL): Debts to Book Capitalization

Brandmark of NEXGEL Inc. (NXGL)

Leveraging advancements in polymer chemistry for wound healing, NEXGEL, Inc. has established a foundation for growth. The current balance sheet leverage ratio demonstrates financial maturity, with the metric standing at 1.59. The company's prospects are based on its proprietary electronic cross-linking of materials and the expansion of sales through strategic B2B partnerships with cosmetic brands.

NXGL (NEXGEL Inc) Debt to Book Value history from 07/04/2022 to 10/27/2026
Original product of NEXGEL Inc

This indicator reflects the dynamics of the total liabilities-to-equity ratio, reacting promptly to changes in debt load. The metric measures financial stability by determining the balance between capital security and the efficiency of borrowed funds utilization. For NEXGEL, Inc., which focuses on organic growth and strategic acquisitions, this parameter confirms a conservative approach to financing. Analyzing the extent to which balance sheet capital covers debt obligations allows for the timely detection of stagnation risks resulting from the underutilization of financial leverage.

Who NEXGEL, Inc. competes with

ISRG - Debts to Book Capitalization|Debt to Book Value Ratio danaher.com DHR|Debts to Book Capitalization BDX (Becton Dickinson)|STE - Debts to Net Assets|WST (West Pharmaceutical Services Inc) - Debts to Book Capitalization|Baxter Healthcare (BAX) - Debt to Book Value|MASI (Masimo Corporation) - Debts to Book Capitalization|Debts to Book Capitalization STVN|Debt to Book Capitalization Ratio Teleflex (TFX)|Debt to Book Capitalization Ratio Merit Medical Systems, Inc. MMSI|Debt to Book Value Envista Holdings Corp|Debt to Net Assets Ratio ICU Medical Inc. ICUI|Debts to Book Capitalization XRAY (DENTSPLY SIRONA Inc.)|LMAT: Debts to Net Assets|Debt to Book Capitalization Ratio AtriCure|STAA (STAAR Surgical Co.) - Debt to Book Value Ratio|NAGE: Debt to Book Capitalization Ratio|Debts to Net Assets ZimVie Corp (ZIMV)|Debt to Book Value AngioDynamics, Inc.|Debt to Book Capital CERS (cerus.com)|Debt to Book Capitalization Ratio Teknova|MGRM - Debt to Net Assets Ratio|Sharps Tech - Debt to Book Value|INFU: Debts to Book Capitalization|UTMD (Utah Medical Products) - Debt to Book Capitalization Ratio|KORU Medical (KRMD) - Debt to Book Value|Debts to Book Capitalization NYXH (Nyxoah)|Debts to Book Value MBOT|Debt to Book Capitalization Ratio Pro-Dex Corp PDEX|Debt to Book Value Ratio Zentek Corp ZTEK|Debt to Book Value Elutia Inc. (ELUT)|milestonescientific.com - Debt to Book Capital|Debt to Book Capitalization Ratio RVP (Retractable Tech)|HBIO: Debts to Net Assets|Debt to Book Capitalization Ratio Femasys Corp|Meihua Medical Technologies Co., Ltd. (MHUA) - Debt to Book Value Ratio|Debts to Book Capitalization POAI (Predictive Oncology Inc)|Debts to Book Value Callan JMB Corp (CJMB)|Debt to Book Value Atrion ATRI|Debt to Book Value Ratio NeuroMetrix Inc (NURO)